We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HMC icon
6526
PUT
Honda
HMC
$39.7B
$259K ﹤0.01%
+7,600
New +$246K
GNRX
6527
DELISTED
VanEck Vectors Generic Drugs ETF
GNRX
$259K ﹤0.01%
+10,661
New +$248K
FWRD icon
6528
PUT
Forward Air
FWRD
$487M
$258K ﹤0.01%
+4,500
New +$257K
KN icon
6529
PUT
Knowles
KN
$3.38B
$258K ﹤0.01%
17,600
-6,300
-26% -$98.5K
MANH icon
6530
PUT
Manhattan Associates
MANH
$11.2B
$258K ﹤0.01%
+5,200
New +$233K
TGH
6531
CALL
DELISTED
Textainer Group Holdings limited
TGH
$258K ﹤0.01%
12,000
-1,300
-10% -$26.8K
STON
6532
PUT
DELISTED
StoneMor Inc.
STON
$258K ﹤0.01%
39,400
+5,600
+17% +$37.6K
OMCL icon
6533
PUT
Omnicell
OMCL
$1.69B
$257K ﹤0.01%
+5,300
New +$267K
TRVG
6534
CALL
trivago
TRVG
$366M
$257K ﹤0.01%
7,520
-6,740
-47% -$276K
WSC icon
6535
WillScot Mobile Mini Holdings
WSC
$4.81B
$257K ﹤0.01%
+20,202
New +$216K
CVA
6536
PUT
DELISTED
Covanta Holding Corporation
CVA
$257K ﹤0.01%
+15,200
New +$235K
MEET
6537
PUT
DELISTED
The Meet Group, Inc. Common Stock
MEET
$257K ﹤0.01%
91,100
+49,800
+121% +$148K
ABG icon
6538
PUT
Asbury Automotive
ABG
$3.94B
$256K ﹤0.01%
4,000
-500
-11% -$31.2K
FBT icon
6539
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.75B
$256K ﹤0.01%
+2,052
New +$254K
GEF.B icon
6540
Greif Class B
GEF.B
$4.23B
$256K ﹤0.01%
3,687
-4,678
-56% -$299K
IOVA icon
6541
Iovance Biotherapeutics
IOVA
$1.94B
$256K ﹤0.01%
31,944
-23,380
-42% -$188K
RH icon
6542
RH
RH
$3.7B
$256K ﹤0.01%
2,969
-161,580
-98% -$14.6M
EWGS
6543
DELISTED
iShares MSCI Germany Small-Cap ETF
EWGS
$256K ﹤0.01%
+3,977
New +$246K
ELVT
6544
DELISTED
Elevate Credit, Inc.
ELVT
$256K ﹤0.01%
33,953
-45,735
-57% -$339K
ALG icon
6545
Alamo Group
ALG
$2.04B
$255K ﹤0.01%
+2,256
New +$252K
ASPS icon
6546
CALL
Altisource Portfolio Solutions
ASPS
$63.8M
$255K ﹤0.01%
1,138
-1,337
-54% -$286K
BY icon
6547
Byline Bancorp
BY
$1.79B
$255K ﹤0.01%
+11,101
New +$231K
CYTK icon
6548
CALL
Cytokinetics
CYTK
$10.7B
$255K ﹤0.01%
31,300
-2,800
-8% -$31.8K
HLNE icon
6549
Hamilton Lane
HLNE
$5.56B
$255K ﹤0.01%
+7,192
New +$222K
BLCM
6550
PUT
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$255K ﹤0.01%
3,030
-270
-8% -$26.5K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.